Baker & McKenzie
Learn about us Locally »
English (Change Language)
Baker & McKenzie
Learn about us Locally
and/or
Combining the knowledge of local laws and cultures with a global reach is just one of the ways Baker & McKenzie separates itself from other firms. Our genuinely global perspective allows us to operate without boundaries around the world, in every jurisdiction that is important to your business.

Select a region or country to learn about on-the-ground resources immersed in the local culture or Learn about us Globally to view our talent and services worldwide.

When content is available in multiple languages, please select your preference on the right.

View All 16-30 of 78
Date Title
2015
Featured Content

2014 was a record year for mergers and acquisitions in the pharmaceutical sector with USD363 billion spent, and that momentum has continued into 2015. Baker & McKenzie's new report Dealing with Uncertainty shows that emerging markets will continue to offer the best growth in the sector but also present extra risks and uncertainties.

Our survey of life sciences executives reveals the primary challenges in cross-border M&A are ensuring corporate compliance and managing regulatory uncertainty.

December 2014
Client/Legal Alert
Turkish authorities recently banned the export of pharmaceutical products imported into Turkey and placed on the Turkish market. The Turkish Medicines and Medical Devices Authority announced the ban in Circular No. 2014/11 on 20 November 2014.
November 2014
Client/Legal Alert
On 11 November 2014, the Council of State suspended Article 1.6 of the Communiqué on Healthcare Practices, which requires healthcare service providers to confirm the identity of applicants for health services with biometric data. Following the decision, registration of applicants' biometric data in the Social Security Institution's database is no longer possible, at least until a final court decision.
26 June 2014
Featured Content
Dr. Christian Lopez Silva and Alvaro Gutierrez discuss their experience on BIO 2014 and speak about important topics such as biosimilars and the Pacific Alliance.
July - August 2014
Newsletter
This newsletter summarises key regulatory and legal developments in the pharmaceuticals sector and healthcare industry in Europe.
July/August 2014
Newsletter
This newsletter summarizes key regulatory and legal developments in the pharmaceuticals sector and healthcare industry in Europe.
June 2014
Newsletter
This newsletter summarises key regulatory and legal developments in the pharmaceuticals sector and healthcare industry in Europe
May 2014
Newsletter
This newsletter summarises key regulatory and legal developments in the pharmaceuticals sector and healthcare industry in Europe.
April 2014
Client/Legal Alert
The Russian Government has for some time been developing draft regulations limiting participation of medical devices that originate from abroad in Russian state/municipal procurement. Prior drafts of such regulations were rather complex and had mechanisms build into them aimed at ensuring that the prohibition is only applicable when Russian analogues of the relevant medical devices exist. Recently a new draft of the regulations has been published. This new draft establishes that certain medical devices may not be purchased within state/municipal procurement.
April 2014
Newsletter
This newsletter summarizes key regulatory and legal developments in the pharmaceuticals sector and healthcare industry in Europe.
April 2014
Newsletter
This is the Pharmaceuticals & Healthcare Newsletter April 2014 issue.
3 March 2014
Book
In a series of exclusive interviews with top private equity players and advisers, our third annual private equity report discusses the latest global industry trends and offers tips for private equity and infrastructure investors on how to get deals closed.
March 2014
Newsletter
This newsletter summarizes key regulatory and legal developments in the pharmaceuticals sector and healthcare industry in Europe.
March 2014
Newsletter
This is the Pharmaceuticals & Healthcare Newsletter March 2014 issue.
March 2014
Newsletter
This newsletter summarizes key regulatory and legal developments in the pharmaceuticals sector and healthcare industry in Europe.
 
View All 16-30 of 78
Search Globally






or
Search Globally
Alphabetical by Last Name
Every day our more than 4,000 lawyers, economists, tax advisors and other professionals share insights and best practices across borders and practices. We speak more than 75 languages and represent more than 55 nationalities, and the close relationships among our people fosters the trust needed to develop and deliver world-class solutions to multinational clients.

We share an uncompromising commitment to excellence, which explains why more of our lawyers are included as leading lawyers in the Chambers Global Guide to the World’s Best Lawyers than any other Global 20 law firm.

To find a Baker & McKenzie lawyer or other professional, enter a search parameter to the left.
Passionately global
We are passionately global — it's in our DNA.

We started with a vision of going global and were in eight countries before our 10th anniversary. Today we have 77 offices in 47 countries -- including the emerging markets so important to the growth of your business.
*Associated Firms
**In cooperation with Trench, Rossi and Watanabe Advogados
Other Geographic Initiatives

We service clients throughout the world and in some countries where we do not have offices, working with carefully selected local firms to leverage our global knowledge and capabilities.

 India Africa Central America 
  Central Europe   
We offer world-class career opportunities around the globe, while our entrepreneurial culture makes Baker & McKenzie a unique place to develop professionally.

Explore us Locally by selecting a region, country or office below, or select Submit to view our site Globally.